| Value | ₹17.11 Cr |
|---|
BSE filing, NSE: VINATIORGA. Summary written from the filing by ALFA Finder's alert engine.
Vinati Organics Ltd: key numbers
- Share price
- ₹1,081.70
- Market cap
- ₹11,214 Cr
- Revenue (annual)
- ₹2,227 Cr
- Net profit (annual)
- ₹443.7 Cr
- P/E (TTM)
- 25.0×Sector 34.1×
- Promoter holding
- 74.28%+0.00% QoQ
- FII holding
- 3.64%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vinati Organics Ltd
All →Vinati Organics Board Meeting Date
Vinati Organics informed BSE and NSE that its Board is scheduled for 30 Oct 2026 to approve unaudited Q1/H1 FY27 results. Trading window closure runs from 1 Oct 2026 till 48 hours post-meeting.
Vinati Organics Other Announcement
The company filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ended September 30, 2026, as required by SEBI regulations.
Vinati Organics Credit Rating
CARE Ratings has reaffirmed the long-term and short-term bank facility credit ratings for Vinati Organics Limited as CARE AA+ Stable and CARE A1+.
Vinati Organics Business Update
Vinati Organics Limited announced that Managing Director & CEO Ms. Vinati Saraf Mutreja gave an interview to CNBC-TV18. The discussion focused on general business updates.
Vinati Organics Annual General Meeting
Vinati Organics declared a final dividend of ₹8.50 per share at its 37th AGM on September 23, 2026. A retiring director was reappointed and WTD remuneration revised.
Vinati Organics Acquisition Worth ₹9.03 Cr
Vinati Organics acquires 100% of Veeral Organics Pvt Ltd for ₹9.03 Crore cash. The target makes specialty chemicals aligned with Vinati's core business.
- Value
- ₹9.03 Cr
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr